Safety immunogenicity and protective efficacy in mice of a new cell-cultured Lister smallpox vaccine candidate

被引：16

作者：

Ferrier-Rembert, Audrey ^{[4
]}

Drillien, Robert ^{[2
,3
]}

Meignier, Bernard ^{[1
]}

Garin, Daniel ^{[4
]}

Crance, Jean-Marc ^{[4
]}

机构：

[1] Sanofi Pasteur, Marcy LEtoile, France

[2] INSERM, IGBMC, U596, CNRS,UMR7104, F-67400 Illkirch Graffenstaden, France

[3] Univ Strasbourg, F-67000 Strasbourg, France

[4] CRSSA, Virol Unit, F-38702 Grenoble, France

来源：

VACCINE | 2007年 / 25卷 / 49期

关键词：

mice; smallpox vaccine; vaccinia; cowpox; smallpox; variola; immunogenicity; protection;

D O I：

10.1016/j.vaccine.2007.09.050

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

It is now difficult to manufacture the first-generation smallpox vaccine, as the process could not comply with current safety and manufacturing regulations. In this study, a candidate non-clonal second-generation smallpox vaccine developed by Sanofi-Pasteur from the Lister strain has been assessed using a cowpox virus challenge in mice. We have observed similar safety, immunogenicity and protection (from disease and death) after a short or long interval following vaccination, as well as similar virus clearance post-challenge, with the second-generation smallpox vaccine candidate as compared to the traditional vaccine used as a benchmark. (C) 2007 Elsevier Ltd. All rights reserved.

引用

页码：8290 / 8297

页数：8

共 50 条

[31] Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies [J].

Kozlovskaya, Liubov, I ;

Piniaeva, Anastasia N. ;

Ignatyev, Georgy M. ;

Gordeychuk, Ilya, V ;

Volok, Viktor P. ;

Rogova, Yulia, V ;

Shishova, Anna A. ;

Kovpak, Anastasia A. ;

Ivin, Yury Yu ;

Antonova, Liliya P. ;

Mefyod, Kirill M. ;

Prokosheva, Lyubov S. ;

Sibirkina, Anna S. ;

Tarasova, Yuliya Yu ;

Bayurova, Ekaterina O. ;

Gancharova, Olga S. ;

Illarionova, Victoria V. ;

Glukhov, Grigory S. ;

Sokolova, Olga S. ;

Shaitan, Konstantin, V ;

Moysenovich, Anastasia M. ;

Gulyaev, Stanislav A. ;

Gulyaeva, Tatiana, V ;

Moroz, Andrey, V ;

Gmyl, Larissa, V ;

Ipatova, Elena G. ;

Kirpichnikov, Mikhail P. ;

Egorov, Alexey M. ;

Siniugina, Aleksandra A. ;

Ishmukhametov, Aydar A. .

EMERGING MICROBES & INFECTIONS, 2021, 10 (01) :1790-1806

[32] Construction, characterization and evaluation of the protective efficacy of the Streptococcus suis double mutant strain ΔSsPep/ΔSsPspC as a live vaccine candidate in mice [J].

Hu, Jin ;

You, Wujin ;

Wang, Bin ;

Hu, Xueying ;

Tan, Chen ;

Liu, Jinlin ;

Chen, Huanchun ;

Bei, Weicheng .

MICROBIOLOGICAL RESEARCH, 2015, 170 :87-94

[33] Safety, Immunogenicity, and Protective Efficacy of an H5N1 Chimeric Cold-Adapted Attenuated Virus Vaccine in a Mouse Model [J].

Sun, Weiyang ;

Wang, Zhenfei ;

Sun, Yue ;

Li, Dongxu ;

Zhu, Menghan ;

Zhao, Menglin ;

Wang, Yutian ;

Xu, Jiaqi ;

Kong, Yunyi ;

Li, Yuanguo ;

Feng, Na ;

Wang, Tiecheng ;

Zhao, Yongkun ;

Yang, Songtao ;

Gao, Yuwei ;

Xia, Xianzhu .

VIRUSES-BASEL, 2021, 13 (12)

[34] Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice [J].

Nishiyama, Yasumasa ;

Fujii, Tatsuya ;

Kanatani, Yasuhiro ;

Shinmura, Yasuhiko ;

Yokote, Hiroyuki ;

Hashizume, So .

VACCINE, 2015, 33 (45) :6120-6127

[35] Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants (vol 15, 1307546, 2024) [J].

Teixeira, Franciane Mouradian Emidio ;

Oliveira, Luana de Mendonca ;

Branco, Anna Claudia Calvielli Castelo ;

Alberca, Ricardo Wesley ;

de Sousa, Emanuella Sarmento Alho ;

Leite, Bruno Henrique de Sousa ;

Adan, Wenny Camilla dos Santos ;

Duarte, Alberto Jose da Silva ;

Lins, Roberto Dias ;

Sato, Maria Notomi ;

Viana, Isabelle Freire Tabosa .

FRONTIERS IN IMMUNOLOGY, 2024, 15

[36] The Protective Efficacy of a SARS-CoV-2 Vaccine Candidate B.1.351V against Several Variant Challenges in K18-hACE2 Mice [J].

Yang, Jie ;

Fan, Huifen ;

Yang, Anna ;

Wang, Wenhui ;

Wan, Xin ;

Lin, Fengjie ;

Yang, Dongsheng ;

Wu, Jie ;

Wang, Kaiwen ;

Li, Wei ;

Cai, Qian ;

You, Lei ;

Pang, Deqin ;

Lu, Jia ;

Guo, Changfu ;

Shi, Jinrong ;

Sun, Yan ;

Li, Xinguo ;

Duan, Kai ;

Shen, Shuo ;

Meng, Shengli ;

Guo, Jing ;

Wang, Zejun .

VACCINES, 2024, 12 (07)

[37] Live attenuated Leishmania infantum centrin deleted mutant (LiCen-/-) as a novel vaccine candidate: A field study on safety, immunogenicity, and efficacy against canine leishmaniasis [J].

Zarei, Zabihollah ;

Mohebali, Mehdi ;

Dehghani, Hesam ;

Khamesipour, Ali ;

Tavakkol-Afshari, Jalil ;

Akhoundi, Behnaz ;

Abbaszadeh-Afshar, Mohammad Javad ;

Alizadeh, Zahra ;

Eskandari, Seyed Ebrahim ;

Asl, Abdolhossein Dalimi ;

Razmi, Gholam Reza .

INFECTIOUS DISEASES, 2023, 97

[38] Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers [J].

Kulkarni, Prasad S. ;

Sapru, Amita ;

D'costa, Pradeep M. ;

Pandit, Anand ;

Madhusudana, Shampur N. ;

Yajaman, Ashwin Belludi ;

Mangrule, Somnath ;

Gunale, Bhagwat ;

Bavdekar, Ashish R. .

VACCINE, 2013, 31 (24) :2719-2722

[39] Live attenuated Leishmania major p27 gene knockout as a novel vaccine candidate: A study on safety, protective immunity and efficacy against canine leishmaniasis caused by Leishmania infantum [J].

Elikaee, S. ;

Zarei, Z. ;

Khamesipour, A. ;

Akhoundi, B. ;

Borjian, A. R. ;

Afshar, M. J. Abbaszadeh ;

Allely, Q. K. ;

Heidari, S. ;

Mohebali, M. .

ACTA TROPICA, 2022, 225

[40] Immunogenicity and safety of purified vero cell-cultured rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in the healthy Chinese subjects: a randomized, double-blind, positive controlled phase 3 clinical trial [J].

Shen, Heng ;

Wang, Zhao ;

Yang, Beifang ;

Cai, Kun ;

Jiang, Changjun ;

Xie, Ronghua ;

Xiao, Haitao ;

Ren, Qunhui ;

Qi, Zhengxu ;

Li, Jinghui ;

Li, Qiong ;

Ye, Jianjun ;

Zhan, Faxian .

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (02) :351-357

← 1 2 3 4 5 →